Concepedia

Dana Masin

DM

Statistics

Publications

33

Citations

2.5K

H-Index

26

Active since

1989

Affiliations

University of British Columbia(Current)

BC Cancer Agency

Centre for Drug Research and Development

Inimex Pharmaceuticals (Canada)

Parker Hannifin (United States)

Dana Masin is an author at University of British Columbia specializing in pharmacology, pharmacy, and liposomal formulations.

Publications per year

1989–2015

33

Publications

33

Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.

Lawrence D. Mayer, Linda C.L. Tai, Dicken S. C. Ko et al. · PubMed · 1989 · 355 citations

, , +17

Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models

MS Webb, TO Harasym, Dana Masin et al. · British Journal of Cancer · 1995 · 242 citations · Full text

, , +15

Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.

Paul Tardi, EDWARD CHOICE, Dana Masin et al. · PubMed · 2000 · 159 citations · Full text

, , +16

Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.

Nancy L. Boman, Dana Masin, L.D. Mayer et al. · PubMed · 1994 · 126 citations

, , +15

Accumulation of Liposomal Lipid and Encapsulated Doxorubicin in Murine Lewis Lung Carcinoma: The Lack of Beneficial Effects by Coating Liposomes with Poly(ethylene glycol)

Michael Parr, Dana Masin, Pieter R. Cullis et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 126 citations

, , +16

1–5 of 33